Skip to content

Checked

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT07064473 on ClinicalTrials.gov

Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.

Status
Recruiting
Phase
Phase 3
Interventional
Planned enrollment
11,800
Participants, all sites
U.S. sites
208
In 39 states

Study details

Conditions
Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
Sponsor
Boehringer Ingelheim (Industry)
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Start
07/22/2025
Primary completion (expected)
12/14/2029
Last updated by sponsor
10/14/2026

Full eligibility rules, contacts and site names: NCT07064473 on ClinicalTrials.gov

Where the study has sites

Cities with at least one listed U.S. site. Some sites may not be enrolling yet.

  • Alabama: Anniston, Fairhope, Guntersville
  • Arizona: Chandler, Phoenix, Sun City West, Tempe, Tucson, Yuma
  • California: Beverly Hills, Canoga Park, Concord, Huntington Park, La Mesa, Lancaster, Long Beach, Orange, Pomona, San Bernardino, San Diego, Santa Rosa and 2 more
  • Colorado: Aurora, Golden
  • Connecticut: Bridgeport, Hamden, Stamford
  • Florida: Miami (6), Jacksonville (4), DeLand (2), Boca Raton, Clearwater, Cutler Bay, Doral, Fleming Island, Fort Myers, Hallandale, Kissimmee, Lake City and 15 more
  • Georgia: Columbus, Johns Creek, Macon, Marietta, Savannah, Thomasville, Tucker
  • Hawaii: Honolulu
  • Idaho: Idaho Falls
  • Illinois: Chicago (2), Lombard, Oak Lawn
  • Indiana: Avon, Elkhart, Franklin, Greenfield, Muncie, Richmond
  • Kansas: El Dorado, Topeka, Wichita
  • Kentucky: Bowling Green, Lexington, Owensboro
  • Louisiana: Bossier City, Covington, Monroe, Shreveport, Slidell, West Monroe, Zachary
  • Maryland: Baltimore, Olney, Oxon Hill, Salisbury
  • Massachusetts: Malden, Methuen
  • Michigan: Flint (2), Dearborn, Troy
  • Mississippi: Fayette
  • Missouri: St Louis (2), Jefferson City, Kansas City
  • Montana: Billings
  • Nebraska: Fremont, Omaha
  • Nevada: Las Vegas (5), North Las Vegas
  • New Jersey: Bridgewater, Linden, Somerset
  • New Mexico: Albuquerque (2)
  • New York: New York (2), Albany, Binghamton, Buffalo, Riverhead, Rochester, Saratoga Springs, West Seneca, Westfield
  • North Carolina: Cary, Chapel Hill, Greenville, Lenoir, Mooresville, Morehead City, Wilmington, Winston-Salem
  • North Dakota: Fargo
  • Ohio: Cincinnati (2), Columbus (2), Westlake
  • Oklahoma: Oklahoma City (2)
  • Pennsylvania: Philadelphia (2), Pittsburgh (2), Beaver, Camp Hill, Scottdale, Smithfield, Uniontown, West Chester, Yardley
  • South Carolina: Fort Mill, Gaffney, Greenville, Union
  • South Dakota: Dakota Dunes
  • Tennessee: Knoxville
  • Texas: San Antonio (5), Dallas (4), Fort Worth (3), Brownsville (2), Houston (2), Austin, El Paso, Forney, Lewisville, Mesquite, San Marcos, Shavano Park and 5 more
  • Utah: Salt Lake City, West Jordan
  • Virginia: Falls Church, Manassas, Norfolk, Richmond, Winchester
  • Washington: Tacoma
  • West Virginia: Morgantown
  • Wisconsin: Kenosha, Wausau, Wauwatosa

More studies on the same topic

Frequently asked questions

What does recruiting mean?
Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
How do I join a clinical trial?
Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.

Source: ClinicalTrials.gov, National Library of Medicine · Last updated 10/14/2026